J Biomater Appl
Conflicts of Interest Eva Vilarrasa has received fees for consulting and/or as a speader and/or for travel and/or has participated in clinical trials sponsored by Abbvie, Almirall, Amgen, Boehringer Ingelheim, Bristol-Meyers Squibb, Celgene, Gebro, Isdin, Janssen, LEO Pharma, Lilly, Merck Serono, MSD, Novartis, Pfizer, Roche, Sandoz, Sanofi, and UCB
On the contrary, the inhibition of mTORC1 is required for the fasting-induced activation of PPAR and the activation of hepatic ketogenesis [38]
The reference materials listed below are provided for background review of sterile research preparation standards, preservative-system context, reconstitution handling practices, and formulation specifications relevant to laboratory workflows